Paxlovid Pfizer

• U.S. FDA orders Pfizer to test 2nd Paxlovid course for rebound COVID patients

  The U.S. FDA has ordered Pfizer Inc PFE.N to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment

  Health

  Aug 19, 2022
  
• Paxlovid oral treatment fails to prevent COVID-19 in household members: Pfizer

  Pfizer said a large trial found that its Paxlovid treatment was not effective at preventing infection in people living with someone who had been exposed to the virus.

  Health

  Apr 29, 2022
  
• Advertisement
• Paxlovid, Pfizer’s oral COVID-19 pill, approved in Canada

  Pfizer began a rolling submission with Health Canada in December for Paxlovid, which it said is designed to block a key enzyme needed for the COVID-19 virus to multiply.

  Health

  Jan 17, 2022